| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |